Shares of DexCom (NASDAQ: DXCM) were trading up by 13.9% as of 11:55 a.m. ET Friday. The big gain came after the diabetes-care technology company announced its third-quarter results following the market close on Thursday.

DexCom reported Q3 revenue of $769.6 million, up 18% year over year. It posted earnings of $101.2 million, or $0.24 per diluted share, based on generally accepted accounting principles (GAAP). In the prior-year period, it recorded GAAP earnings of $87.3 million, or $0.21 per diluted share.

Analysts' consensus estimate for DexCom's Q3 non-GAAP earnings had been $0.24 per share. It easily beat those expectations with non-GAAP earnings of $111.9 million, or $0.28 per diluted share.

Continue reading

Source Fool.com